HMS Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
HMS Capital Management's UTHR Position: Q3 2026 in Review
HMS Capital Management reduced its United Therapeutics (UTHR) stake by 0.79% in Q3 2026, selling an estimated $5.17K and leaving 1,248 shares worth $676K. The position accounts for 0.26% of the portfolio, ranked #71.
HMS Capital Management first reported a position in UTHR in Q3 2024 and has held it in 9 quarters since. The position peaked at $784K in Q1 2026. 838 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- HMS Capital Management held 1,248 shares of United Therapeutics worth $676K as of Q3 2026.
- HMS Capital Management sold 10 United Therapeutics shares in Q3 2026, an estimated $5.17K.
- United Therapeutics made up 0.26% of HMS Capital Management's portfolio in Q3 2026, its #71 holding.
- HMS Capital Management first reported a position in United Therapeutics in Q3 2024 and has held it in 9 quarters since.
- HMS Capital Management's United Therapeutics position peaked at $784K in Q1 2026.
- 838 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on HMS Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.